Stay updated on ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer
Sign up to get notified when there's something new on the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page.

Latest updates to the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page
- ChecktodayChange DetectedA site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.2%

- Check7 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.7.2 instead of v3.7.1.SummaryDifference0.0%

- Check14 days agoChange DetectedThe footer’s site revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedAdded a new Study Status entry to the study's record history on 2026-09-25, with a cross-reference to 2026-09-24 and the number 122. This documents an update to the study's current status within the history log.SummaryDifference0.1%

- Check35 days agoChange DetectedThe revision history now includes a new entry for Revision v3.7.0 and removes the previous entry v3.6.6, updating the page's version history.SummaryDifference0.0%

- Check56 days agoChange DetectedA new version entry (Revision: v3.6.6) dated 2026-08-28 was added to the history, and the previous revision (v3.6.5) was removed; this introduces an updated Study Status in the record timeline.SummaryDifference0.2%

Stay in the know with updates to ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page.